Related Experiment Video
Updated: Jun 6, 2026

Rescue of Recombinant Newcastle Disease Virus from cDNA
Published on: October 11, 2013
Anti-adenoviral effect of interferon-β and interferon-γ in serotypes that cause acute keratoconjunctivitis
Eiichi Uchio1, Hirotoshi Inoue, Aki Fuchigami
1Department of Ophthalmology, Fukuoka University School of Medicine, Fukuoka,Japan. euchio@fukuoka-u.ac.jp
Background:
Interferons are currently used for hepatitis B and C virus infection; the effect of interferons against adenovirus has not been elucidated. It has been reported that interferon-β and interferon-γ were effective against adenovirus serotype 3. We investigated the anti-adenoviral effect of interferon-β and interferon-γ in serotypes that cause acute keratoconjunctivitis, using quantitative polymerase chain reaction in vitro.
Design:
Experimental study carried out in a university.
Samples:
Five strains of different serotypes of adenovirus, types 3 (AdV3; species B), 4 (species E), 8, 19a and 37 (species D) and interferon-β and interferon-γ for in vitro assay.
Methods:
After pretreatment of A549 with serial dilution of interferons for 24 h, adenovirus was cultivated for 7 days, and adenoviral DNA was quantitatively measured by real-time polymerase chain reaction.
Main Outcome Measures:
Number of virus copies after treatment and the 50% effective concentration (EC(50) ).
Results:
Interferon-β showed a dose-dependent inhibitory effect on all serotypes. EC(50) of interferon-β ranged between 211 and 843 IU/mL. A similar tendency was observed with interferon-γ. EC(50) of interferon-γ ranged between 133 and 9130 IU/mL. Among the serotypes, interferon-γ exhibited the greatest inhibitory effect on AdV37. In contrast, AdV4 showed the lowest sensitivity to interferon-γ. Statistically significant dose dependency for both interferon-β and interferon-γ was observed in several serotypes.
Conclusions:
These results suggest that both interferon-β and interferon-γ have anti-adenoviral activity in vitro. Interferons have the potential to be used for local treatment of adenoviral keratoconjunctivitis, although further evaluation in animal models and clinical trials is necessary.
Insights
Interferon-beta and interferon-gamma demonstrate in vitro anti-adenoviral activity against key serotypes. These findings suggest potential for treating adenoviral keratoconjunctivitis, pending further trials.
Area of Science:
- Virology
- Immunology
- Ophthalmology
Background:
- Interferons are established treatments for hepatitis B and C virus infections.
- The efficacy of interferons against adenovirus, particularly in causing acute keratoconjunctivitis, remains largely unelucidated.
- Previous studies indicated potential effectiveness of interferon-beta and interferon-gamma against adenovirus serotype 3.
Purpose of the Study:
- To investigate the in vitro anti-adenoviral effects of interferon-beta and interferon-gamma.
- To evaluate the efficacy of these interferons against adenovirus serotypes responsible for acute keratoconjunctivitis.
- To determine the dose-dependent inhibitory effects and quantify the 50% effective concentration (EC50) for each interferon-adenovirus serotype combination.
Main Methods:
- An experimental in vitro study was conducted using A549 cells.
- Five adenovirus serotypes (AdV3, AdV4, AdV8, AdV19a, AdV37) and interferon-beta and interferon-gamma were utilized.
- Adenoviral DNA was quantified using real-time polymerase chain reaction after 24-hour interferon pretreatment and 7-day adenovirus cultivation.
Main Results:
- Interferon-beta exhibited a dose-dependent inhibitory effect across all tested adenovirus serotypes, with EC50 values ranging from 211 to 843 IU/mL.
- Interferon-gamma also demonstrated a dose-dependent anti-adenoviral effect, with EC50 values ranging from 133 to 9130 IU/mL.
- Interferon-gamma showed the strongest inhibition against AdV37, while AdV4 displayed the lowest sensitivity to interferon-gamma. Dose dependency was statistically significant for both interferons against several serotypes.
Conclusions:
- Both interferon-beta and interferon-gamma possess significant in vitro anti-adenoviral activity.
- These interferons show promise for the local treatment of adenoviral keratoconjunctivitis.
- Further research, including animal model studies and clinical trials, is warranted to confirm therapeutic potential.
More Related Videos
07:27Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
Published on: December 18, 2012
11:13Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
Published on: April 7, 2016
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Virion Maturation and Assembly
Antiviral Nucleoside Inhibitors
Inhibitors Of Virion Release
Cytomegalovirus Disease